Navigation auf uzh.ch

Suche

UZH News

Archive Medicine and Dentistry 2015

Article list Medicine and Dentistry

  • Wyss Translational Center Zurich

    Bridge to Practice

    On Monday evening the Wyss Translational Center Zurich was inaugurated in an official ceremony. The aim of the new development center, set up by the University and ETH Zurich with a donation from entrepreneur Hansjörg Wyss, is to translate innovative ideas from pure research more rapidly into practice.
  • Clinical Research Priority Programs (CRPPs)

    Research Initiative Makes the Grade

    External evaluators have given UZH’s Clinical Research Priority Programs the thumbs-up. The program, designed to support efforts at the interface of research and clinical practice, is now entering Phase 2.
  • Clinical Research Priority Program

    When Oxygen Levels are Low

    Low levels of oxygen can lead to aggressive tumor growth. Researchers on the Tumor Oxygenation Clinical Research Priority Program (CCRP) are pursuing various promising methodological, clinical, and preclinical approaches in an effort to find out why this is so.
  • North-South Collaboration

    Medicine under the equatorial sky

    A symposium will be held on 24/25 August devoted to the North-South Cooperation between UZH and Uganda. As part of the preparations, journalist Ruedi Küng went along on the trip to the Ugandan capital, Kampala, and reports for UZH News on his impressions.
  • Clinical Research Priority Program

    Riding to Success in Tandem

    The Molecular Imaging Network Zurich – “MINZ” for short – has the goal of improving diagnostic and therapeutic imaging techniques. MINZ is one of the University of Zurich’s eleven clinical research priority programs (CRPPs). UZH News is presenting a series of features on these.
  • Clinical Research Priority Program

    Tracking down Viruses

    The aim of the Viral Infectious Diseases Clinical Research Priority Program is to track down dormant human immunodeficiency viruses, and find unidentified pathogens that plague people with weak immune systems. This is part of a series of UZH News articles featuring the Clinical Research Priority Programs.
  • Human Lactation Research

    Breastfeeding is Healthy. But Why?

    We still don’t know why breastfeeding protects children from illness and infection. But that’s about to change. Thanks to funding from the Family Larsson-Rosenquist Foundation, the world’s first medical professorship for human lactation research is to be set up at UZH.
  • Clinical Research Priority Program

    Rare Diseases: Not as Rare as You Think

    The Rare Disease Initiative Zurich (radiz) is a CCRP revolving around developing improved treatments for patients with rare diseases. It’s one of the University of Zurich’s eleven clinical research priority programs. UZH News is presenting a series of features on these programs.
  • Startup-Competition

    First Prize for “Cutiss”

    Last week the prizewinners in the Swiss startup competition “venture” were announced. First prize went to “Cutiss,” a new company that aims to bring customized skin grafts to market using lab-grown skin developed at the University Children’s Hospital Zurich.
  • Clinical Research Priority Programs

    Getting to Grips with the Blood and Immune System

    The Human Hemato-Lymphatic Diseases Clinical Research Priority Program (CRPP) is all about finding better therapies for serious blood disorders and infections. The CRPP is one of the University of Zurich’s eleven clinical research priority programs. UZH News is presenting a series of features on these programs.
  • Cardiology

    Broken Hearts

    A ventricle that looks like a Japanese octopus trap, and symptoms resembling a coronary: Zurich cardiologists are researching the mysterious and dangerous “broken heart syndrome”.
  • Clinical Research Priority Program

    The Heterogeneity of Multiple Sclerosis

    There are many different types of multiple sclerosis. The University of Zurich’s Clinical Research Priority Program on Multiple Sclerosis is trying to identify the different forms the disease takes as a basis for developing new treatments. 
  • Cancer Research

    Outwitting the Immune System

    An American biotech firm is developing a new antibody to combat cancer that also improves the patient’s feeling of well-being. Its work is based on research done by Zurich dermatologist Thomas Kündig.
  • University Children’s Hospital Zurich

    The Burning Issue of Poverty

    The University Children’s Hospital Zurich is helping a hospital in the Afghan capital Kabul improve care for children with burn injuries. The premises have been renovated, and now it’s time to train the staff.
  • RNA-Research

    Cracking the Prion Puzzle

    A multidisciplinary team around prion researcher Adriano Aguzzi is using small RNA molecules to gain deeper insights into disease processes. “Small RNAs” is one of the University of Zurich’s eleven clinical research priority programs (CRPPs). UZH News is presenting a series of features on these programs.
  • Cooperation with Japan

    Technology for Aging

    Last week researchers from Japan and Switzerland met at a workshop in Tokyo to discuss ways modern technology could facilitate healthy aging. The co-organizer of the workshop, UZH gerontologist Mike Martin, talked to us about the background to the meeting.
  • Neurorehabilitation

    Doctor on Your Wrist

    It’s in the wake of paraplegia, a stroke or multiple sclerosis that the strengths of the brain really come into play: To some extent it can compensate for deficiencies. Physicians and engineers on the Neuro-Rehab Clinical Research Priority Program (CRPP) at UZH are investigating the brain’s plasticity and working on tailored training programs for the patients affected.
  • Proteomics

    Personalising medicine with proteins

    Ruedi Aebersold, Professor of Systems Biology has developed the proteomics method together with a team of international researchers to such an extent that doctors and clinical researchers can now use this technique as a tool. In a conversation, the professor at ETH and the University of Zurich explains how information from proteins can advance personalised medicine.
  • Clinical Research Priority Program

    New Therapies for Liver Cancer

    The liver is the only organ in the human body that can regrow. The Liver Tumors Clinical Research Priority Program is looking into how this ability can be used to cure liver cancer. This is one of a series of UZH News articles featuring the eleven Clinical Research Priority Programs.
  • Clinical Research Priority Program

    Skin from the Petri Dish

    UZH researchers are attempting to create skin substitutes that can be transplanted from the petri dish to people with burns and skin conditions. Their endeavors are bearing fruit, with the first usable skin grafts currently undergoing clinical trials. Skin Grafts for Zurich is one of the University of Zurich’s eleven clinical research priority programs (CRPPs). UZH News will be presenting a series of features on these programs.
  • Swiss National Science Foundation

    Four Consolidator Grants for Junior Researchers at UZH

    Junior researchers at UZH have been awarded four of the Swiss National Science Foundation’s 21 Consolidator Grants. One of these researchers is microbiologist Anne Müller. She is investigating Helicobacter pylori, a bacterium that can trigger gastric cancer, but also protects against allergies.
  • Microbiology

    Secret Weapon: Garlic

    With bacteria developing resistance, it’s become harder and harder for antibiotics to penetrate their defenses. This is why microbiologists like Leo Eberl are looking for ways to trick the microorganisms, disrupting them as they speak and eat. 
  • Clinical Research Priority Programs

    A Boost for Sleep Research

    A hectic lifestyle has lead to sleep problems and a chronic sleep deficit for many people. Under its Sleep and Health Clinical Research Priority Program (CRPP), the University of Zurich is seeking more effective therapies for sleep disorders and trying to gain a deeper understanding of the functions of sleep.
  • Virology

    Globetrotting Quick-Change Artist

    Flu viruses mutate constantly, and can be very dangerous for humans. Virologist Lars Hangartner is working on a vaccine giving long-term protection against all potential flu viruses.